Papers: 10.1186/s13058-020-01271-0
https://doi.org/10.1186/s13058-020-01271-0
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
Cited by: 25
Author(s): Claudio Vernieri, Francesca Corti, Federico Nichetti, Francesca Ligorio, Sara Manglaviti, Emma Zattarin, Carmen G. Rea, Giuseppe Capri, Giulia Bianchi, Filippo de Braud
Published: over 5 years ago
Software Mentions 1
Very Likely Science (100)